What have we learned from the calcium channel blocker controversy?
Publication
, Journal Article
Califf, RM; Kramer, JM
Published in: Circulation
April 28, 1998
Duke Scholars
Published In
Circulation
DOI
ISSN
0009-7322
Publication Date
April 28, 1998
Volume
97
Issue
16
Start / End Page
1529 / 1531
Location
United States
Related Subject Headings
- Hypertension
- Humans
- Cardiovascular System & Hematology
- Calcium Channel Blockers
- Arteriosclerosis
- Animals
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M., & Kramer, J. M. (1998). What have we learned from the calcium channel blocker controversy? Circulation, 97(16), 1529–1531. https://doi.org/10.1161/01.cir.97.16.1529
Califf, R. M., and J. M. Kramer. “What have we learned from the calcium channel blocker controversy?” Circulation 97, no. 16 (April 28, 1998): 1529–31. https://doi.org/10.1161/01.cir.97.16.1529.
Califf RM, Kramer JM. What have we learned from the calcium channel blocker controversy? Circulation. 1998 Apr 28;97(16):1529–31.
Califf, R. M., and J. M. Kramer. “What have we learned from the calcium channel blocker controversy?” Circulation, vol. 97, no. 16, Apr. 1998, pp. 1529–31. Pubmed, doi:10.1161/01.cir.97.16.1529.
Califf RM, Kramer JM. What have we learned from the calcium channel blocker controversy? Circulation. 1998 Apr 28;97(16):1529–1531.
Published In
Circulation
DOI
ISSN
0009-7322
Publication Date
April 28, 1998
Volume
97
Issue
16
Start / End Page
1529 / 1531
Location
United States
Related Subject Headings
- Hypertension
- Humans
- Cardiovascular System & Hematology
- Calcium Channel Blockers
- Arteriosclerosis
- Animals
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services